Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ODE/OIVD Fiscal 2003 Annual Report In Brief

This article was originally published in The Gray Sheet

Executive Summary

Expedited PMAs review times: Average total review time for expedited PMA applications approved by the Office of Device Evaluation and the Office of In Vitro Diagnostic Device Evaluation & Safety in FY 2003 is 374.7 days, down from 471 days in FY 2002. However, the FY 2003 figure is still nearly 16 days greater than the average time for approved original PMAs. Elapsed FDA days averaged 304 for the six expedited submissions - 58 days longer than for the total PMA approval cohort mean. In November, FDA released a guidance on the expedited review program (1"The Gray Sheet" Dec. 1, 2003, p. 9)...
Advertisement

Related Content

Third-Party 510(k) Reviews Increasingly Time-Consuming For CDRH – Kahan
Third-Party 510(k) Reviews Increasingly Time-Consuming For CDRH – Kahan
CDRH FY 2005 Budget Proposal Designates 12 New FTEs For Outside Expertise
FDA Guidance Aims To Hit MDUFMA Expedited Review Performance Goals
FDA Guidance Aims To Hit MDUFMA Expedited Review Performance Goals
FDA Analyte-Specific Reagent Guidance Spells Out Small Lab Fundamentals
510(k) User Fee Rates May Make Third-Party Review More Attractive Option
Advertisement
UsernamePublicRestriction

Register

MT019720

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel